CytomX Therapeutics' IPO

CytomX Therapeutics raised a round of funding on October 08, 2015. Investors include Public.

CytomX Therapeutics is a biotechnology company developing Probody therapeutics for the treatment of cancer. Probodies are masked antibodies that remain inert in healthy tissue but are activated specif…

Articles about CytomX Therapeutics' IPO: